# Bernhard Hemmer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bernhard-hemmer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,126 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 103 |
| i10-index | 389 |
| Last Known Institution | TUM Klinikum |
| OpenAlex ID | https://openalex.org/A5023893355 |
| ORCID iD | https://orcid.org/0000-0001-5985-6784 |
| Works | 626 |

## Researcher papers

Showing 12 of 13.

- [Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis](https://scholariq.org/papers/analysis-of-immune-related-loci-identifies-48-new-susceptibility-variants-for/)
- [Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility](https://scholariq.org/papers/multiple-sclerosis-genomic-map-implicates-peripheral-immune-cells-and-microglia/)
- [Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients](https://scholariq.org/papers/contrasting-disease-patterns-in-seropositive-and-seronegative-neuromyelitis/)
- [ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis](https://scholariq.org/papers/ectrims-ean-guideline-on-the-pharmacological-treatment-of-people-with-multiple/)
- [Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis](https://scholariq.org/papers/retinal-layer-segmentation-in-multiple-sclerosis-a-systematic-review-and-meta/)
- [Myelin-oligodendrocyte glycoprotein antibody-associated disease](https://scholariq.org/papers/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/)
- [Consensus guidelines for lumbar puncture in patients with neurological diseases](https://scholariq.org/papers/consensus-guidelines-for-lumbar-puncture-in-patients-with-neurological-diseases/)
- [Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelitis-optica-spectrum-disorders/)
- [Apheresis therapies for NMOSD attacks](https://scholariq.org/papers/apheresis-therapies-for-nmosd-attacks/)
- [DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis](https://scholariq.org/papers/dna-methylation-as-a-mediator-of-hla-drb1-15-01-and-a-protective-variant-in/)
- [Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk](https://scholariq.org/papers/low-frequency-and-rare-coding-variation-contributes-to-multiple-sclerosis-risk/)
- [Cell-based therapeutic strategies for multiple sclerosis](https://scholariq.org/papers/cell-based-therapeutic-strategies-for-multiple-sclerosis/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [TUM Klinikum](https://scholariq.org/institutions/tum-klinikum/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.